Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.
Quick take
A syphilis blood test is a blood test used to look for evidence of infection with Treponema pallidum, the bacterium that causes syphilis. Most blood tests do not directly find the bacterium. Instead, they look for antibodies your immune system makes during or after infection.
- Most accurate interpretation uses two test types: a nontreponemal test such as RPR or VDRL and a treponemal test such as TPPA, EIA, or CIA. The CDC explains that a presumptive diagnosis generally requires both kinds of serologic tests, interpreted with symptoms and exposure history.
- No fasting is usually needed. Testing is typically a standard blood draw or, in some settings, a fingerstick rapid test.
- A positive result is not always simple. It may mean current infection, past treated infection, untreated past infection, or, less commonly, a false-positive result. Discordant results often need reflex testing or repeat testing.
- RPR and VDRL titers matter after diagnosis. The number reported as a titer, such as 1:8 or 1:32, helps clinicians follow treatment response or evaluate possible reinfection. Titers from different test methods should not be treated as interchangeable.
- Do not wait if you are pregnant, have symptoms, or had a known exposure. Syphilis is treatable, but untreated infection can cause serious complications and can be passed to a fetus during pregnancy.
Bottom line: A syphilis blood test is best understood as a testing algorithm, not a single yes-or-no blood draw. The result pattern, your symptoms, prior treatment history, pregnancy status, and timing of exposure all affect what the result means.
What does a syphilis blood test measure?
A syphilis blood test measures antibodies associated with syphilis infection. Syphilis is caused by Treponema pallidum. Because the organism is difficult to grow in routine clinical laboratories, everyday testing relies mainly on blood-based serology: tests that detect immune response rather than directly detecting the bacterium.
The CDC Laboratory Recommendations for Syphilis Testing, United States, 2024 divide syphilis blood tests into two broad groups: nontreponemal tests and treponemal tests. Nontreponemal tests detect antibodies that react with lipid-type antigens associated with cellular damage and the organism. Treponemal tests detect antibodies directed more specifically against T. pallidum.
This distinction is important because the two test groups answer different questions:
- Nontreponemal tests, such as RPR and VDRL, are often used to estimate disease activity and monitor treatment response through a titer.
- Treponemal tests, such as TPPA, EIA, CIA, and some rapid treponemal tests, are often used to confirm exposure to the syphilis organism. These antibodies commonly remain detectable for life, even after successful treatment.
For that reason, a single positive treponemal test does not automatically prove an active, untreated infection. It may reflect a current infection, an infection treated years ago, or a result that needs confirmation. Likewise, a negative test soon after exposure may be too early to rule out infection.
Who should consider a syphilis blood test?
Testing can be used for either screening, when you do not have symptoms but may be at risk, or diagnostic evaluation, when symptoms or a known exposure raise concern.
You should consider discussing syphilis testing with a clinician or clinic if any of the following apply:
- You had sex with a partner who told you they have syphilis or another sexually transmitted infection.
- You have a painless sore, ulcer, rash on the palms or soles, swollen lymph nodes, unexplained fever, patchy hair loss, or other symptoms that could fit syphilis.
- You are pregnant or planning pregnancy.
- You have a new partner, multiple partners, or a partner with other partners.
- You are a man who has sex with men, especially if you have multiple partners or use HIV pre-exposure prophylaxis.
- You live in or receive care in a community with higher syphilis rates.
- You have HIV or another STI diagnosis.
The U.S. Preventive Services Task Force recommends syphilis screening for nonpregnant adolescents and adults at increased risk. The CDC also recommends syphilis testing during pregnancy; its pregnancy screening information says all pregnant women should be tested during each pregnancy, with repeat testing in certain higher-risk situations or higher-prevalence areas.
If you are pregnant and have a reactive syphilis test, contact your pregnancy care clinician promptly. Timely treatment can prevent congenital syphilis, but interpretation and treatment decisions should not be delayed while trying to decode results alone.
Types of syphilis blood tests
Many people hear “syphilis test” and assume there is only one test. In practice, laboratories use named tests and reflex algorithms. The order can vary by lab, clinic, and public health program.
| Test type | Common examples | What it is commonly used for | Important limitation |
|---|---|---|---|
| Nontreponemal blood tests | RPR, VDRL | Screening in some settings, diagnosis with a treponemal test, baseline titer, monitoring treatment response | Can be falsely reactive; can be nonreactive in very early infection; titers vary by method and lab |
| Treponemal blood tests | TPPA, EIA, CIA, FTA-ABS, treponemal rapid tests | Confirming exposure to T. pallidum; first-line screening in reverse-sequence algorithms | Often stays reactive after treatment, so it usually cannot tell current from past infection by itself |
| Reflex confirmatory testing | Second treponemal test after a reactive EIA/CIA and nonreactive RPR | Clarifying discordant results | May still require clinical history, prior records, and repeat testing |
| CSF testing for neurosyphilis evaluation | CSF-VDRL plus CSF cell count/protein in selected cases | Used only when neurologic, eye, or ear findings suggest possible neurosyphilis, ocular syphilis, or otosyphilis | Not a routine screening test; requires clinician-directed evaluation |
Traditional algorithm
In a traditional testing algorithm, the lab starts with a nontreponemal test, usually RPR or VDRL. If it is reactive, a treponemal test is performed to support the diagnosis. This approach has been common in public health and clinical settings for many years.
Reverse sequence algorithm
In a reverse sequence algorithm, the lab starts with an automated treponemal immunoassay, often EIA or CIA. If it is reactive, the lab performs a nontreponemal test such as RPR. If the treponemal test is reactive but the RPR is nonreactive, a second treponemal test, often TPPA, may be used to help sort out whether this reflects past treated infection, untreated infection, early infection, or a false-positive screening result. The CDC’s syphilis treatment guidance describes this reverse sequence approach and emphasizes that results need clinical interpretation, not just automated reporting.
How to prepare for a syphilis blood test
Most people do not need special preparation for syphilis blood testing. You can usually eat and drink normally before the blood draw unless other tests ordered at the same time require fasting.
Helpful preparation steps include:
- Bring a list of recent exposures and symptoms. Timing matters because very early infection may not be detected immediately.
- Tell the clinician if you were treated for syphilis before. Prior treatment can leave treponemal tests reactive for years, so old records can prevent confusion.
- Share pregnancy status. Pregnancy changes the urgency of evaluation and follow-up.
- Ask which tests are being ordered. “Syphilis screen” may mean RPR, treponemal EIA/CIA with reflex RPR, or another algorithm.
- Ask how you will receive results. Some reactive results require prompt treatment, partner notification, or repeat testing.
If you are testing after a recent exposure, avoid sex or use barrier protection until a clinician tells you what your results mean and whether treatment is needed. If you have an open sore, rash, neurologic symptoms, vision changes, hearing changes, or pregnancy-related concerns, do not rely on an at-home or delayed testing plan alone; seek medical evaluation.
What happens during the test?
For a standard lab-based syphilis blood test, a phlebotomist or healthcare worker collects blood from a vein in your arm. The blood draw itself usually takes only a few minutes. Some clinics and outreach programs may use fingerstick rapid tests, but a reactive rapid result may still need lab-based confirmation and clinical follow-up.
Turnaround time depends on the setting. Public health clinics, urgent care centers, primary care offices, hospital laboratories, and direct-to-consumer lab ordering services may all handle workflows differently. If the first test triggers reflex testing, the final result may take longer than a single-screen result.
How to read syphilis blood test results
Syphilis results can be confusing because they may include words such as “reactive,” “nonreactive,” “positive,” “negative,” “titer,” “reflex,” or “discordant.” The meaning depends on which test was performed first and whether another test confirmed it.
| Result pattern | Possible meaning | Common next step |
|---|---|---|
| Nontreponemal nonreactive and treponemal nonreactive | No lab evidence of syphilis at the time of testing | If exposure was recent or symptoms are present, repeat testing or exam may still be needed |
| Nontreponemal reactive and treponemal reactive | Consistent with syphilis infection, but stage and treatment need depend on history and exam | Clinical evaluation, staging, treatment plan, partner services, and baseline titer documentation |
| Treponemal reactive, RPR/VDRL nonreactive, second treponemal reactive | Could be past treated infection, untreated late infection, or early infection before RPR becomes reactive | Review prior treatment records; clinician may repeat RPR in several weeks if recent exposure is possible |
| Treponemal reactive, RPR/VDRL nonreactive, second treponemal nonreactive | May be a false-positive initial treponemal screen in a low-risk person | Clinician interpretation; repeat testing may be considered if exposure risk or symptoms exist |
| Previously treated syphilis with persistent low RPR titer | May represent a “serofast” pattern rather than active infection, depending on history | Compare with prior titers and symptoms; do not interpret one number in isolation |
What does an RPR titer mean?
An RPR titer is a dilution number. Examples include 1:1, 1:2, 1:4, 1:8, 1:16, and 1:32. Higher numbers generally mean more antibody reactivity in that sample, but the titer is not a simple “severity score.” A person with early infection, reinfection, or untreated infection may have a higher titer, but individual patterns vary.
Clinicians use titers most importantly for comparison over time. A fourfold change is usually the key unit of change. For example, a decline from 1:32 to 1:8 is a fourfold decline; an increase from 1:4 to 1:16 is a fourfold increase. The CDC laboratory recommendations emphasize that nontreponemal tests such as RPR and VDRL should not be used interchangeably for monitoring titers because methods and labs can vary. If possible, follow-up testing should use the same test method and, ideally, the same laboratory.
Can a positive test show when I got syphilis?
Usually not by itself. A blood test pattern can support diagnosis, but it cannot reliably date the infection without exposure history, prior negative tests, symptoms, exam findings, and past treatment records. Syphilis is staged clinically as primary, secondary, latent, tertiary, or involving neurologic, eye, or ear systems in selected cases. Stage affects treatment and follow-up, so it is a clinician decision rather than a lab-only label.
Limitations, false positives, and false negatives
Syphilis blood testing is useful and widely used, but it has limitations.
Testing too early can miss infection
After exposure, it takes time for antibodies to become detectable. If you test very soon after a possible exposure, a nonreactive result may not be final. If symptoms or exposure history are concerning, a clinician may recommend repeat testing. This is one reason a single negative test cannot always answer “Am I definitely clear?” immediately after exposure.
Nontreponemal tests can be falsely reactive
RPR and VDRL can be reactive for reasons other than syphilis. The CDC notes that false-positive nontreponemal results can occur with other infections, recent vaccination, injection drug use, autoimmune conditions, and other chronic conditions. That is why a reactive RPR or VDRL is typically interpreted with a treponemal test and the clinical picture.
Treponemal tests often stay positive after treatment
Many people remain treponemal-test reactive for life after syphilis, even when treatment was successful. This can surprise people who test years later and see a positive treponemal antibody result. In that situation, old treatment records and RPR titer trends are often more useful than repeating the same treponemal test.
Symptoms can require care even if results are unclear
Syphilis can cause painless sores, rashes, neurologic symptoms, eye inflammation, hearing changes, and other findings. If test results do not match symptoms, clinicians may use additional evaluation. The CDC treatment guidance notes that when serologic tests do not correspond with clinical findings suggestive of syphilis, presumptive treatment and other diagnostic approaches may be considered for people with risk factors.
What to do after a reactive syphilis blood test
If your result is reactive or positive, do not panic, but do follow up. Syphilis is treatable, and early follow-up helps prevent complications and transmission.
- Confirm which tests were reactive. Ask whether your result includes RPR or VDRL, a treponemal test, and any reflex confirmatory test.
- Ask for the RPR or VDRL titer. If a nontreponemal test is reactive, the baseline titer is important for follow-up.
- Review prior testing and treatment. If you were treated before, bring records if possible.
- Get staged clinically. Treatment depends on stage, symptoms, pregnancy status, and neurologic, eye, or ear findings.
- Discuss partners and recent exposures. Partner notification and treatment can prevent reinfection and community spread.
- Follow the retesting plan. After treatment, repeat titers are used to assess response. The schedule depends on stage and individual circumstances.
Do not use a positive antibody test to self-prescribe antibiotics or assume a specific stage. Syphilis treatment is effective, but the medication regimen and follow-up plan should be clinician-directed.
Cost, insurance, and access
The cost of a syphilis blood test depends on where you test, whether reflex confirmation is included, whether a blood draw fee is charged, and whether you use insurance, a public health clinic, or a self-pay lab option. A quoted “test price” may not include all required charges. When comparing self-pay options, compare the effective total cost: the syphilis screen, confirmatory or reflex testing if needed, specimen collection fees, clinician or telehealth ordering fees, and any required follow-up visit.
Public health departments and sexual health clinics may offer low-cost or no-cost STI testing, especially for people with symptoms, known exposure, pregnancy, or higher risk. Insurance coverage varies by plan and indication, but preventive screening recommendations can affect coverage when testing is ordered for people who meet risk-based criteria. If you are using insurance, ask whether the ordering visit, lab draw, and reflex testing are in network.
If you choose direct lab ordering, read the test description carefully. Some products are RPR-only, some are treponemal-only, and some include reflex confirmation. A cheaper test is not always the better value if it leaves you needing a second order to interpret the result.
When a syphilis blood test is not enough
A blood test is only one part of syphilis evaluation. You may need more than a routine blood test if you have:
- Vision changes, eye pain, redness, or light sensitivity
- Hearing loss, ringing in the ears, or dizziness
- Severe headache, confusion, weakness, numbness, or other neurologic symptoms
- A genital, anal, or oral sore that needs direct examination
- Pregnancy with a reactive result or possible exposure
- A history of prior syphilis treatment with rising RPR titers
In these situations, clinical examination and sometimes specialist evaluation matter. Routine blood testing cannot, by itself, diagnose every complication or determine whether symptoms are caused by syphilis.
Practical result questions to ask your clinician or lab
- Was my first test nontreponemal or treponemal?
- Was a confirmatory or reflex test performed?
- If my RPR or VDRL was reactive, what was the titer?
- Do my results suggest current infection, past treated infection, or an unclear pattern?
- Do I need repeat testing because my exposure was recent?
- Do I need testing for HIV, chlamydia, gonorrhea, hepatitis B, hepatitis C, or other STIs?
- If treatment is recommended, when should my follow-up titer be checked?
- Should my partners be notified or treated?
FAQs
Is a syphilis blood test the same as an RPR?
Not always. RPR is one type of syphilis blood test, specifically a nontreponemal test. Many labs use a testing algorithm that may include RPR plus a treponemal test, or a treponemal screen with reflex RPR. Ask which specific tests were included.
Do I need to fast before a syphilis blood test?
Usually no. Syphilis blood testing does not normally require fasting. If your clinician ordered other blood tests at the same time, those tests may have separate instructions.
How soon after exposure should I test?
Testing right away can be useful if you need baseline results or have symptoms, but a very early negative result may not rule out infection. If exposure was recent, a clinician may recommend repeat testing after enough time has passed for antibodies to develop.
Can a syphilis blood test be positive after treatment?
Yes. Treponemal tests often remain reactive for years or for life after successful treatment. RPR or VDRL titers usually decline after treatment, but some people have a persistent low-level titer. Prior records are important for interpretation.
What does “reactive” mean?
“Reactive” means the test detected the antibody pattern it was designed to detect. It does not always mean active, contagious syphilis. The meaning depends on whether the test was nontreponemal or treponemal, whether confirmatory testing was done, and whether you were treated before.
Can I have syphilis with a negative RPR?
Yes, it is possible in some situations, especially very early infection, certain late infections, or when the testing algorithm shows a reactive treponemal test with a nonreactive RPR. Symptoms and exposure history should guide whether repeat or additional testing is needed.
Can syphilis be diagnosed from urine?
Routine syphilis screening is done with blood, not urine. Urine is commonly used for some other STI tests, such as chlamydia or gonorrhea nucleic acid amplification tests, but syphilis diagnosis usually relies on blood serology.
Should my partner test too?
If you have a reactive result, symptoms, or a known exposure, partners may need evaluation and sometimes treatment. Partner management depends on timing, stage, and local public health guidance, so ask your clinician or health department what applies.
Sources
- CDC — Laboratory Recommendations for Syphilis Testing, United States, 2024
- CDC — Syphilis: STI Treatment Guidelines
- CDC — STI Screening Recommendations
- CDC — Syphilis During Pregnancy
- U.S. Preventive Services Task Force — Syphilis Infection in Nonpregnant Adolescents and Adults: Screening
Educational note: This article is for general health education and does not diagnose syphilis or replace care from a qualified clinician. If you have symptoms, are pregnant, had a known exposure, or received a reactive result, seek medical advice promptly.





